Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
28
-
Total shares
-
3.73M
-
Shares change
-
+965K
-
Total reported value, excl. options
-
$47.9M
-
Value change
-
+$13.7M
-
Number of buys
-
21
-
Number of sells
-
-6
-
Price
-
$12.82
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q1 2014
28 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q1 2014.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.73M shares
.
Largest 10 shareholders include JPMORGAN CHASE & CO (1.31M shares), Cormorant Asset Management, LLC (700K shares), FMR LLC (650K shares), BlackRock Institutional Trust Company, N.A. (185K shares), VANGUARD GROUP INC (174K shares), Healthcare Value Capital, LLC (100K shares), BAIRD ROBERT W & CO INC /WI/ (68.6K shares), JANE STREET GROUP, LLC (66.3K shares), GEODE CAPITAL MANAGEMENT, LLC (51.1K shares), and Iguana Healthcare Management, LLC (50K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.